Bogle Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bogle Investment Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-639,856	Closed	-$12.1M	–	401
2017 Q4	$12.1M	Buy	639,856 +408,724	+177%	+$7.4M	0.89%	42
2017 Q3	$3.25M	Buy	+231,132	New	+$2.09M	0.22%	133
2016 Q4	–	Sell	-11,722	Closed	-$54K	–	425
2016 Q3	$54K	Sell	11,722 -402,072	-97%	-$2.38M	﹤0.01%	344
2016 Q2	$2.72M	Buy	+413,794	New	+$2.92M	0.19%	148
2016 Q1	–	Sell	-476,493	Closed	-$2.87M	–	475
2015 Q4	$2.87M	Buy	476,493 +27,034	+6%	+$155K	0.21%	143
2015 Q3	$2.69M	Buy	+449,459	New	+$3.12M	0.19%	153
2015 Q2	–	Sell	-375,464	Closed	-$2.28M	–	444
2015 Q1	$2.28M	Buy	+375,464	New	+$2.5M	0.16%	161

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bogle Investment Management's SPPI Position: Q1 2018 in Review

Bogle Investment Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2018, closing a stake of 639,856 shares — an estimated $12.1M sold.

Bogle Investment Management first reported a position in SPPI in Q1 2015 and held it in 7 quarters. The position peaked at $12.1M in Q4 2017. 161 funds tracked by Wall St. Rank hold SPPI as of Q1 2018.

Bogle Investment Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2018 after selling out during the quarter.
Bogle Investment Management sold 639,856 Spectrum Pharmaceuticals Inc shares in Q1 2018, an estimated $12.1M.
Bogle Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2015 and held it in 7 quarters.
Bogle Investment Management's Spectrum Pharmaceuticals Inc position peaked at $12.1M in Q4 2017.
161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2018.

Based on Bogle Investment Management's 13F filing for Q1 2018, filed 14 May 2018.